According to a new survey of over 2,000 employed people from Gallup and West Health, almost a quarter of all U.S. workers say they want to leave their current job but won't because they want to keep their health benefits.
GSK has shelved its chronic cough treatment, camlipixant, after mixed Phase 3 data prompted the British pharma to cease development, making it the third from its class to fail.
Sens. Richard Blumenthal (D-Conn.) and Josh Hawley (R-Mo.) are calling on the nation's largest Medicare Advantage insurers to provide internal records and detailed information on their use of artificial intelligence to block rehabilitative care.
Northwest Biotherapeutics' brain cancer treatment, DCVax, has been under review for over 931 days after submitting a marketing application to the U.K.'s Medicines and Healthcare products Regulatory Agency in late December 2023.
The employer-based health insurance system in the U.S. is crumbling, with a high likelihood that workers get their health insurance from their job or the job of a loved one.
Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program after failing to receive comprehensive claims data.
The chair of the U.S. Senate health committee, Sen. Bill Cassidy (R-La.), introduced a bill to restrict the federal 340B drug discount program that has been lucrative for nonprofit hospitals.
Following Vijay Kumar's exit, acting CBER Director Karim Mikhail will oversee a review office that has become a battleground for debates on FDA flexibility.
The Centers for Medicare and Medicaid Services (CMS) has proposed expanding Medicare coverage for transcatheter aortic valve replacement (TAVR) procedures, which could help Edwards Lifesciences gain market share from Medtronic and Boston Scientific.